Eli Lilly and Company (NYSE:LLY) is one of the 13 Best Low Risk High Growth Stocks to Buy. Amid carrying on new studies, the ...

Eli Lilly (LLY) recently entered a collaboration with Gate Bioscience to develop molecular gate therapeutics, a move that ...

Lilly has 11 obesity drugs in its pipeline and wants to develop more ... Eli Lilly will invest $4.5 billion to ... Any new advances could help Lilly become the first trillion ...

Eli Lilly (LLY) has outperformed the S&P index and its competitors during the past 5 years, LLY has a broad product portfolio, a robust pipeline that is built to power market performance.

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 trillion stock and the first healthcare company to do so. Trading at $852 per ...

We are increasing Eli Lilly’s fair value estimate to $500 from $450 following solid fourth-quarter results with robust sales from diabetes drug Mounjaro and strong pipeline advancements running ...

Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline By Angelica Peebles,CNBC • Published October 2, 2024 • Updated on October 2, 2024 at 10:55 am ...

Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer’s disease, ALS and other brain diseases, CEO David Ricks said.